To gain insight into the underlying mechanism of JWA in trastuzumab-resistant breast cancer, we found that overexpression of JWA significantly downregulated CDK12 levels in JIMT1 and BT474-Tr cells (Fig. 6B, C). This evidence concerns the gene ARL6IP5 and breast cancer.